These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 16266447)

  • 1. Anthropology, DOTS and understanding tuberculosis control in Nepal.
    Harper I
    J Biosoc Sci; 2006 Jan; 38(1):57-67. PubMed ID: 16266447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Translating ethics: researching public health and medical practices in Nepal.
    Harper I
    Soc Sci Med; 2007 Dec; 65(11):2235-47. PubMed ID: 17897762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leadership, management and technical lessons learnt from a successful public-private partnership for TB control in Nepal.
    Newell JN; Pande SB; Baral SC; Bam DS; Malla P
    Int J Tuberc Lung Dis; 2005 Sep; 9(9):1013-7. PubMed ID: 16158894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extreme condition, extreme measures? Compliance, drug resistance, and the control of tuberculosis.
    Harper I
    Anthropol Med; 2010 Aug; 17(2):201-14. PubMed ID: 20721757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The research agenda for improving health policy, systems performance, and service delivery for tuberculosis control: a WHO perspective.
    Nunn P; Harries A; Godfrey-Faussett P; Gupta R; Maher D; Raviglione M
    Bull World Health Organ; 2002; 80(6):471-6. PubMed ID: 12132005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health sector reform in Brazil: impact on tuberculosis control.
    Kritski AL; Ruffino-Netto A
    Int J Tuberc Lung Dis; 2000 Jul; 4(7):622-6. PubMed ID: 10907764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health policy, systems and services research and the Revised National Tuberculosis Control Programme.
    Wares DF; Chauhan LS
    J Indian Med Assoc; 2003 Mar; 101(3):177-9. PubMed ID: 14603971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Directly observed treatment, short-course (DOTS): ensuring cure of tuberculosis.
    Frieden TR
    Indian J Pediatr; 2000 Feb; 67(2 Suppl):S21-7. PubMed ID: 11129903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reform of tuberculosis control and DOTS within Russian public health systems: an ecological study.
    Marx FM; Atun RA; Jakubowiak W; McKee M; Coker RJ
    Eur J Public Health; 2007 Feb; 17(1):98-103. PubMed ID: 16837521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Development and perspectives of community DOTS].
    Narita T; Kobayashi N
    Kekkaku; 2009 Apr; 84(4):187-201. PubMed ID: 19425394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress towards tuberculosis elimination in Cuba.
    González E; Armas L; Llanes MJ
    Int J Tuberc Lung Dis; 2007 Apr; 11(4):405-11. PubMed ID: 17394686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ten-year experiences of the tuberculosis control programme in the southern region of Ethiopia.
    Yassin MA; Datiko DG; Shargie EB
    Int J Tuberc Lung Dis; 2006 Oct; 10(10):1166-71. PubMed ID: 17044212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barriers to care seeking in directly observed therapy short-course (DOTS) clinics and tuberculosis control in southern Nigeria: a qualitative analysis.
    Okeibunor JC; Onyeneho NG; Chukwu JN; Post E
    Int Q Community Health Educ; 2006-2007; 27(1):23-37. PubMed ID: 18039627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. World Health Organization press release. WHO sees surge in progress against tuberculosis on eve of global summit.
    World Health Organization
    Saudi Med J; 2004 Aug; 25(8):1140-1. PubMed ID: 15457609
    [No Abstract]   [Full Text] [Related]  

  • 15. Tuberculosis control: how the world has changed since 1990.
    Hopewell PC
    Bull World Health Organ; 2002; 80(6):427. PubMed ID: 12131995
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment outcome of neuro tuberculosis patients put on DOTS--an observation study from the field.
    Venugopal K; Sreelatha PR; Philip S; Kumar V
    Indian J Tuberc; 2008 Oct; 55(4):199-202. PubMed ID: 19295107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic evaluation of public-private mix for tuberculosis care and control, India. Part II. Cost and cost-effectiveness.
    Pantoja A; Lönnroth K; Lal SS; Chauhan LS; Uplekar M; Padma MR; Unnikrishnan KP; Rajesh J; Kumar P; Sahu S; Wares F; Floyd K
    Int J Tuberc Lung Dis; 2009 Jun; 13(6):705-12. PubMed ID: 19460245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementing WHO DOTS strategy in the Russian Federation: stakeholder attitudes.
    Atun RA; Baeza J; Drobniewski F; Levicheva V; Coker RJ
    Health Policy; 2005 Oct; 74(2):122-32. PubMed ID: 16153473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of multidrug-resistant tuberculosis: Update 2007.
    Yew WW; Leung CC
    Respirology; 2008 Jan; 13(1):21-46. PubMed ID: 18197909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.